SAB BIO(SABSW)
MIAMI BEACH, FLBiotechnology
Focus: SAB BIO is a public biotechnology platform company specializing in fully human, polyclonal antibodies with focus on oncology. Founded in 2014 and headquartered in Miami Beach, the company operates at an early clinical stage with minimal revenue generation.
Profile data last refreshed 5h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
9
Should You Work at SAB BIO?
AI assessmentSAB BIO offers early-stage platform upside and recent manufacturing validation, but severe cash depletion and absent clinical data present material near-term viability risk for job seekers.
Why Work Here
- Platform-focused biotech with differentiated technology in fully human polyclonal antibodies, offering opportunity to build early-stage scientific IP
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$1M
Help build intelligence for SAB BIO
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.